About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of Prevalence of EGFR Mutations in Participants With NSCLC

NCT02695849·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hoffmann-La Roche

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Informed consent form signature
Jordanian male and female participants greater than or equal to (\>=) 18 years of age
Histologically confirmed NSCLC
Not participating in a study that involves an investigational agent within 30 days prior to enrollment

You may not be if

Other primary malignancy
Fine needle aspiration samples

The record

StatusCompleted

PhaseNo phase

Taking part69

StartedMar 2012

UpdatedJul 4, 2016

Conditions

Non-Small Cell Lung Cancer

Where2

Amman, Jordan
Amman, Jordan

Clareo Health | A Study of Prevalence of EGFR Mutations in Participants With NSCLC